+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Intravenous Solutions Market Size, Share & Trends Analysis Report by Product (TPN, PPN), Nutrients (Carbohydrates, Vitamins & Minerals, Single-dose Amino Acids) by Region (Asia Pacific, North America), and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 114 Pages
  • November 2023
  • Region: Global
  • Grand View Research
  • ID: 3934162
Description Jump to:
The global intravenous solutions market size is expected to reach USD 22.0 billion by 2030, registering a CAGR of 8% during the forecast period, according to the report. The high prevalence of preterm births, especially in emerging economies such as India and China, is expected to drive market growth during the forecast period. According to WHO, 1 in 10 babies are born preterm, and this is a global concern. Thus, the high incidence of preterm births in emerging economies, improved healthcare infrastructure, and growing healthcare expenditure & patient awareness are expected to be high impact rendering drivers of the market during the forecast period.

The use of parenteral lipid emulsions is driven by the extensive focus of various authorities to limit preterm birth mortality. As of 2021, the preterm birth rate in the U.S. was about 10.5%. Moreover, the annual societal, and economic cost was estimated at USD 25.2 billion for preterm births. Hence, the presence of many neonates requiring supplementary postbirth nutrition is expected to boost the market demand over the forecast period.

In addition, several studies justify the use of parenteral nutrition for patients suffering from malnutrition problems, which increased during the pandemic, leading to market growth. For instance, according to an article published in the Journal of the Academy of Nutrition and Dietetics, many patients admitted to the ICU for COVID-19 treatment suffer from acute malnourishment. Hence, the usage of parenteral nutrition products is expected to increase in the market during the pandemic.

In COVID-19-positive patients, high deficiency of specific micronutrients and vitamins has been reported to be detrimental. Thus, intravenous administration is recommended in such patients to meet the recommended dietary intake. Physicians and nutrition specialists preferred parenteral nutrition over enteral nutrition in COVID-19 patients since enteral nutrition specifically requires the setup of nasogastric tubes, which hampers the noninvasive ventilation provided to COVID-19 patients. The increased risk of nutritional solution aspiration and underfeeding in hospitalized patients for COVID-19 has led to increased adoption of parenteral nutrition.

Intravenous Solutions Market Report Highlights

  • In 2023, the Total Parenteral Nutrition (TPN) segment held a dominant market share of 66.3% and is projected to experience the highest growth rate (CAGR of 8.2%) during the forecast period. TPN involves administering a comprehensive set of nutrients through an intravenous (IV) technique
  • In 2023, the market was led by the single-dose amino acid solution segment, holding a significant share of 31.6%. Studies have shown that single-dose amino acids offer a complete protein source, are easily customizable with other parenteral formulations, and are straightforward to administer
  • In 2023, North America held a dominant market share of 41%, credited to key players, favorable regulations, and strong reimbursement in countries like the U.S. Assure Infusions, Inc. announced a USD 20 million investment to build an advanced manufacturing facility in Bartow, Florida, addressing the IV solutions demand-supply gap in the U.S.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.1.1 Segment Definitions
1.1.1.1 Product Segment
1.1.1.2 Nutrient Segment
1.2 Regional Scope
1.3 Estimates And Forecast Timeline
1.4 Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Internal database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information Or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.9.1.1 Research Scope And Assumptions
1.10 List Of Secondary Sources
1.11 List Of Primary Sources
1.12 List Of Abbreviations
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape
Chapter 3 Intravenous Solutions Market Variables And Trends
3.1 Intravenous Solutions Market Lineage Outlook
3.1.1 Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Driver Impact Analysis
3.2.1.1 Growing Number Of Premature Births
3.2.1.2 Increasing Incidence Of Cancer
3.2.1.3 Increasing Risk Of Malnutrition
3.2.1.4 Growing Geriatric Population
3.2.2 Market Restraint Analysis
3.2.2.1 Shortage Of Parenteral Nutrition Products
3.2.2.2 Increased Use Of Enteral Nutrition
3.2.2.3 High Risk Of Infections
3.3 Regulatory Framework
3.3.1 Standards And Compliances
3.3.1.1 North America
3.3.1.2 Europe
3.3.1.3 Apac
3.3.1.4 Latin America
3.3.1.5 Mea
3.3.2 Reimbursement Scenario
3.3.2.1 U.S.
3.3.2.2 Canada
3.3.2.3 Germany
3.3.2.4 UK
3.3.2.5 Japan
3.3.2.6 Australia
3.3.2.7 China
3.4 Impact Of Covid-19 Pandemic
3.5 Industry Analysis Tools
3.5.1 Porter’s Analysis
3.5.2 Macroeconomic Analysis
Chapter 4 Intravenous Solutions Market: Product Analysis
4.1 Product Movement Analysis & Market Share, 2023 & 2030
4.2 Intravenous Solutions Market Estimates & Forecast, By Product (Revenue In USD Million And Volume In Thousand Units)
4.3 Total Parenteral Nutrition
4.3.1 Total Parenteral Nutrition Market, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
4.4 Peripheral Parenteral Nutrition
4.4.1 Peripheral Parenteral Nutrition Market, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
Chapter 5 Intravenous Solutions Market: Nutrients Analysis
5.1 Nutrients Movement Analysis & Market Share, 2023 & 2030
5.2 Intravenous Solutions Market Estimates & Forecast, By Nutrients (Revenue In USD Million And Volume In Thousand Units)
5.3 Carbohydrates
5.3.1 Carbohydrates Market, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
5.4 Single-dose Amino Acid Solution
5.4.1 Single-dose Amino Acid Solution Market, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
5.5 Vitamins & Minerals
5.5.1 Vitamins & Minerals, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
5.6 Parenteral Lipid Emulsion
5.6.1 Parenteral Lipid Emulsion, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
5.7 Others
5.7.1 Others Market, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
Chapter 6 Intravenous Solutions Market: Regional Estimates & Trend Analysis
6.1 Intravenous Solutions Market: Regional Outlook
6.2 North America
6.2.1 North America Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
6.2.2 U.S.
6.2.2.1 Key Country Dynamics
6.2.2.2 U.S. Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
6.2.3 Canada
6.2.3.1 Key Country Dynamics
6.2.3.2 Canada Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
6.3 Europe
6.3.1 Europe Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
6.3.2 UK
6.3.2.1 Key Country Dynamics
6.3.2.2 UK Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
6.3.3 Germany
6.3.3.1 Key Country Dynamics
6.3.3.2 Germany Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
6.3.4 France
6.3.4.1 Key Country Dynamics
6.3.4.2 France Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
6.3.5 Italy
6.3.5.1 Key Country Dynamics
6.3.5.2 Italy Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
6.3.6 Spain
6.3.6.1 Key Country Dynamics
6.3.6.2 Spain Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
6.3.7 Denmark
6.3.7.1 Key Country Dynamics
6.3.7.2 Denmark Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
6.3.8 Sweden
6.3.8.1 Key Country Dynamics
6.3.8.2 Sweden Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
6.3.9 Norway
6.3.9.1 Key Country Dynamics
6.3.9.2 Norway Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
6.4 Asia Pacific
6.4.1 Asia Pacific Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
6.4.2 Japan
6.4.2.1 Key Country Dynamics
6.4.2.2 Japan Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
6.4.3 China
6.4.3.1 Key Country Dynamics
6.4.3.2 China Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
6.4.4 India
6.4.4.1 Key Country Dynamics
6.4.4.2 India Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
6.4.5 Australia
6.4.5.1 Key Country Dynamics
6.4.5.2 Australia Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
6.4.6 South Korea
6.4.6.1 Key Country Dynamics
6.4.6.2 South Korea Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
6.4.7 Thailand
6.4.7.1 Key Country Dynamics
6.4.7.2 Thailand Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
6.5 Latin America
6.5.1 Latin America Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
6.5.2 Mexico
6.5.2.1 Key Country Dynamics
6.5.2.2 Mexico Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
6.5.3 Brazil
6.5.3.1 Key Country Dynamics
6.5.3.2 Brazil Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
6.5.4 Argentina
6.5.4.1 Key Country Dynamics
6.5.4.2 Argentina Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
6.6 Middle East & Africa (Mea)
6.6.1 Mea Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
6.6.3 South Africa
6.6.3.1 Key Country Dynamics
6.6.3.2 South Africa Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
6.6.4 Saudi Arabia
6.6.4.1 Key Country Dynamics
6.6.4.2 Saudi Arabia Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
6.6.5 UAE
6.6.5.1 Key Country Dynamics
6.6.5.2 UAE Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
6.6.6 Kuwait
6.6.6.1 Key Country Dynamics
6.6.6.2 Kuwait Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
Chapter 7 Competitive Analysis
7.1 Company Categorization
7.1.1 Fresenius Kabi AG
7.1.2 Pfizer Inc.
7.1.3 Otsuka Pharmaceutical Co. Ltd.
7.1.4 Baxter, B. Braun Melsungen AG
7.1.5 Vifor Pharma Management Ltd.
7.1.6 JW Life Science
7.2 Participants’ Overview
7.3 Financial Performance
7.4 Product Benchmarking
7.5 Market Participant Categorization
7.5.1 Heat Map Analysis
7.6 Company Market Share Analysis, 2022
7.7 Strategy Mapping
7.7.1 Mergers & Acquisitions
7.7.2 Product Launch
7.7.3 Partnerships & Collaborations
7.7.4 Product Approvals
7.7.5 Expansion
7.7.6 Others
Chapter 8 Analyst Perspective
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
List of Figures
Fig. 1 Intravenous solutions market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market snapshot
Fig. 10 Segment snapshot
Fig. 11 Competitive landscape
Fig. 12 Intravenous solutions market dynamics
Fig. 13 Preterm birth rates in the U.S., 2011 to 2030
Fig. 14 Number of undernourished people in the world, 2015 - 2020 (Million and Percentage)
Fig. 15 Intravenous solutions market: PORTER’s analysis
Fig. 16 Intravenous solutions market: PESTEL analysis
Fig. 17 Intravenous solutions market: by product: key takeaways
Fig. 18 Intravenous solutions market, by product: market share, 2023 & 2030
Fig. 19 Total parenteral nutrition market, 2018 - 2030 (USD Million)
Fig. 20 Peripheral parenteral nutrition market, 2018 - 2030 (USD Million)
Fig. 21 Intravenous solutions market, by end-use: key takeaways
Fig. 22 Intravenous solutions market, by nutrients: market share, 2023 & 2030
Fig. 23 Carbohydrates market, 2018 - 2030 (USD Million)
Fig. 24 Single dose amino acid solution market, 2018 - 2030 (USD Million)
Fig. 25 Vitamins and minerals, 2018 - 2030 (USD Million)
Fig. 26 Parenteral lipid emulsion, 2018 - 2030 (USD Million)
Fig. 27 Others market, 2018 - 2030 (USD Million)
Fig. 28 Intravenous solutions market revenue, by region, 2023 & 2030 (USD Million)
Fig. 29 Regional marketplace: key takeaways
Fig. 30 Regional marketplace: key takeaways
Fig. 31 North America intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 32 Key country dynamics
Fig. 33 U.S. intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 34 Key country dynamics
Fig. 35 Canada intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 36 Europe intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 37 Key country dynamics
Fig. 38 UK intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 39 Key country dynamics
Fig. 40 Germany intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 41 Key country dynamics
Fig. 42 France intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 43 Key country dynamics
Fig. 44 Italy intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 45 Key country dynamics
Fig. 46 Spain intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 47 Key country dynamics
Fig. 48 Denmark intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 49 Key country dynamics
Fig. 50 Sweden intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 51 Key country dynamics
Fig. 52 Norway intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 53 Asia Pacific intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 54 Key country dynamics
Fig. 55 Japan intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 56 Key country dynamics
Fig. 57 China intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 58 Key country dynamics
Fig. 59 India intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 60 Key country dynamics
Fig. 61 Australia intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 62 Key country dynamics
Fig. 63 South Korea intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 64 Key country dynamics
Fig. 65 Thailand intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 66 Latin America intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 Mexico intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 69 Key country dynamics
Fig. 70 Brazil intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 71 Key country dynamics
Fig. 72 Argentina intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 73 MEA intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 South Africa intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 76 Key country dynamics
Fig. 77 Saudi Arabia intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 78 Key country dynamics
Fig. 79 UAE intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 80 Key country dynamics
Fig. 81 Kuwait intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 82 Key company categorization
Fig. 83 Heat map analysis
Fig. 84 Company market share analysis, 2023
Fig. 85 Strategy mapping

Companies Profiled

  • Fresenius Kabi AG
  • Pfizer Inc.
  • Otsuka Pharmaceutical Co. Ltd.
  • Baxter, B. Braun Melsungen AG
  • Vifor Pharma Management Ltd.
  • JW Life Science

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages114
PublishedNovember 2023
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 12.9 Billion
Forecasted Market Value ( USD ) by 2030 $ 22 Billion
Compound Annual Growth Rate8.0%
Regions CoveredGlobal
No. of Companies Mentioned6

Related Topics

Related Reports

Intravenous Solutions Market by Type, Composition Solution, End-users - Global Forecast 2025-2030 - Product Image

Intravenous Solutions Market by Type, Composition Solution, End-users - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Intravenous Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Intravenous Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 250 Pages
  • Global
Intravenous Solutions Market Analysis & Forecast to 2024-2034 - Product Image

Intravenous Solutions Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Intravenous Solutions Global Market Report 2024 - Product Image

Intravenous Solutions Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Intravenous Solutions Market Report by Type (Partial Parenteral Nutrition, Total Parenteral Nutrition), Nutrients (Carbohydrates, Salts and Electrolytes, Minerals, Vitamins, Amino Acids), and Region 2024-2032 - Product Image

Intravenous Solutions Market Report by Type (Partial Parenteral Nutrition, Total Parenteral Nutrition), Nutrients (Carbohydrates, Salts and Electrolytes, Minerals, Vitamins, Amino Acids), and Region 2024-2032

  • Report
  • 141 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.